Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.

Pineda MA, Cuervo H, Fresno M, Soto M, Bonay P.

J Infect Dis. 2015 Oct 1;212(7):1160-71. doi: 10.1093/infdis/jiv185. Epub 2015 Mar 24.

PMID:
25805753
2.

Galectin-3: A Friend but Not a Foe during Trypanosoma cruzi Experimental Infection.

da Silva AA, Teixeira TL, Teixeira SC, Machado FC, Dos Santos MA, Tomiosso TC, Tavares PCB, Brígido RTES, Martins FA, Silva NSL, Rodrigues CC, Roque-Barreira MC, Mortara RA, Lopes DS, Ávila VMR, da Silva CV.

Front Cell Infect Microbiol. 2017 Nov 3;7:463. doi: 10.3389/fcimb.2017.00463. eCollection 2017.

3.

The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi.

Calderón J, Maganto-Garcia E, Punzón C, Carrión J, Terhorst C, Fresno M.

PLoS Pathog. 2012;8(7):e1002799. doi: 10.1371/journal.ppat.1002799. Epub 2012 Jul 12.

4.

Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, Alvarez-Leite JI, Ropert C, Gazzinelli RT.

J Immunol. 2004 Feb 1;172(3):1711-8.

5.

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.

Benatar AF, García GA, Bua J, Cerliani JP, Postan M, Tasso LM, Scaglione J, Stupirski JC, Toscano MA, Rabinovich GA, Gómez KA.

PLoS Negl Trop Dis. 2015 Oct 9;9(10):e0004148. doi: 10.1371/journal.pntd.0004148. eCollection 2015.

6.

Galectin-3 and Chagas Disease-Associated Cardiomyopathy.

Novaes RD, Gonçalves RV, Caldas IS.

J Infect Dis. 2016 Mar 1;213(5):871. doi: 10.1093/infdis/jiv486. Epub 2015 Oct 13. No abstract available.

PMID:
26464205
7.
8.

Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin.

Waghabi MC, Coutinho CM, Soeiro MN, Pereira MC, Feige JJ, Keramidas M, Cosson A, Minoprio P, Van Leuven F, Araújo-Jorge TC.

Infect Immun. 2002 Sep;70(9):5115-23.

9.

TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.

Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, Hisaeda H, Yamamoto M, Akira S, Himeno K, Matsumoto M, Takeda K.

J Immunol. 2006 Nov 15;177(10):7059-66.

10.

The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.

Pellegrini A, Guiñazu N, Giordanengo L, Cano RC, Gea S.

Future Microbiol. 2011 Dec;6(12):1521-33. doi: 10.2217/fmb.11.122. Review.

PMID:
22122446
12.

Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.

Gupta S, Smith C, Auclair S, Delgadillo Ade J, Garg NJ.

PLoS One. 2015 Jun 15;10(6):e0130562. doi: 10.1371/journal.pone.0130562. eCollection 2015.

13.

Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?

Basso B, Marini V.

Immunobiology. 2015 Mar;220(3):428-36. doi: 10.1016/j.imbio.2014.10.003. Epub 2014 Oct 30.

PMID:
25454810
14.

Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity.

Mello DB, Ramos IP, Mesquita FC, Brasil GV, Rocha NN, Takiya CM, Lima AP, Campos de Carvalho AC, Goldenberg RS, Carvalho AB.

PLoS Negl Trop Dis. 2015 Aug 6;9(8):e0003945. doi: 10.1371/journal.pntd.0003945. eCollection 2015.

15.
16.

Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.

Vasconcelos JF, Souza BS, Lins TF, Garcia LM, Kaneto CM, Sampaio GP, de Alcântara AC, Meira CS, Macambira SG, Ribeiro-dos-Santos R, Soares MB.

FASEB J. 2013 Dec;27(12):4691-702. doi: 10.1096/fj.13-229351. Epub 2013 Aug 20. Erratum in: FASEB J. 2015 Nov;29(11):4756.

PMID:
23964077
17.

Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Silverio JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J.

Int J Exp Pathol. 2010 Feb;91(1):72-86. doi: 10.1111/j.1365-2613.2009.00670.x. Epub 2009 Oct 28.

18.

Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection.

Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A.

J Immunol. 2006 Sep 15;177(6):3515-9.

19.

Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.

Oliveira AC, de Alencar BC, Tzelepis F, Klezewsky W, da Silva RN, Neves FS, Cavalcanti GS, Boscardin S, Nunes MP, Santiago MF, Nóbrega A, Rodrigues MM, Bellio M.

PLoS Pathog. 2010 Apr 29;6(4):e1000870. doi: 10.1371/journal.ppat.1000870.

20.

Reply to Novaes et al.

Bonay P, Pineda MA.

J Infect Dis. 2016 Mar 1;213(5):871-3. doi: 10.1093/infdis/jiv487. Epub 2015 Oct 13. No abstract available.

PMID:
26464203

Supplemental Content

Support Center